From 2012.igem.org
(Difference between revisions)
|
|
Line 1: |
Line 1: |
- | {| style="color:#1b2c8a;background-color:#0c6;" cellpadding="3" cellspacing="1" border="1" bordercolor="#fff" width="62%" align="center" | + | {{KIT-Kyoto.Header}} |
- | !align="center"|[[Team:KIT-Kyoto|Home]]
| + | |
- | !align="center"|[[Team:KIT-Kyoto/Team|Team]]
| + | |
- | !align="center"|[https://igem.org/Team.cgi?year=2012&team_name=KIT-Kyoto Official Team Profile]
| + | |
- | !align="center"|[[Team:KIT-Kyoto/Project|Project]]
| + | |
- | !align="center"|[[Team:KIT-Kyoto/Parts|Parts Submitted to the Registry]]
| + | |
- | !align="center"|[[Team:KIT-Kyoto/Modeling|Modeling]]
| + | |
- | !align="center"|[[Team:KIT-Kyoto/Notebook|Notebook]]
| + | |
- | !align="center"|[[Team:KIT-Kyoto/Safety|Safety]]
| + | |
- | !align="center"|[[Team:KIT-Kyoto/Attributions|Attributions]]
| + | |
- | |}
| + | |
- | | + | |
| | | |
| | | |
Revision as of 01:08, 23 August 2012
Project Overview
We try to develop new medicine for therapy of leukemia which is more free from side effects.
For this study, we are going to use Drosophila melanogaster, a model organism to establish transgenic fly carrying responsible genes for human leukemia.
Project Details
Part 2
The Experiments
Part 3
Results